New staging of mesothelioma tumors may predict outcome

Today’s post was shared by Jon L Gelman and comes from

A recent study indicates that a new physician staging processes by weight and volume of mesothelioma tumors may be helpful in predicting outcome. Mesothelioma is a fatal rare tumor and almost always associated with exposure to asbestos fibers. The development of mesothelioma commonly is diagnosed decades after the initial exposure to asbestos fiber.

Today’s post is shared from and reports a significant development in the treatment of the disease.

A new study suggests that significant improvements could be made in the scoring system physicians use to estimate the stage (severity) of mesothelioma, an aggressive and deadly cancer.

The current scoring system incorporates such factors as the size of the tumor and whether it has spread to other parts of the body. The study’s findings suggest that, in addition, tumor weight and volume "may be valuable components for staging malignant pleural mesothelioma."

An improved scoring system could provide a more accurate prognosis and help guide treatment, said lead author Wickii Vigneswaran, MD, MBA, who now is at Loyola University Medical Center and Loyola University Chicago Stritch School of Medicine. Dr. Vigneswaran has performed nearly 200 mesothelioma surgeries, and he is among only a handful of surgeons nationwide who treat mesothelioma surgically.

The study is published in the European Journal of Cardio-Thoracic Surgery. Eur J Cardiothorac Surg (2016)doi: 10.1093/ejcts/ezv422 First published online: January…

[Click here to see the rest of this post]